FDA Warns Against Unsupervised Use of Ketamine for Psychiatric Disorders
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) ...
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) ...
HARTFORD, CT — Connecticut's blossoming cannabis market has reached with ...
DENVER — August witnessed Colorado's recreational cannabis market and its ...
WASHINGTON D.C. — Recent optimism surrounding potential U.S. cannabis banking ...
OTTAWA — A recent report by the Canadian government suggests ...
NEW YORK — Cannabis payment systems have always been rife ...
NEW YORK — In a significant legal triumph, FSD ...
NEW YORK — Atai Life Sciences AG's (Nasdaq: ATAI) confidence ...
NEW YORK — Cannabis microbusinesses in New Mexico may soon ...
LOS ANGELES — In a significant push to bolster its ...